Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C-Reference-Cited by-同舟云学术

Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C

Published:2003-06 Issue:1 Volume:59 Page:1-11
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Pawlotsky Jean-Michel

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference81 articles.

1. Consensus Conferences on Hepatitis C. 2002a. Treatment of hepatitis C. Gastroenterol. Clin. Biol. 26 (Suppl. 2), B303–B320.

2. National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C. 2002b. Hepatology 36 (5 Suppl. 1), S3–S20.

3. Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with two different doses of peginterferon alfa-2b plus ribavirin;Buti;Hepatology,2002

4. Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro;Castet;J. Virol.,2002

5. Interferon-alpha2a/ribavirin versus interferon-alpha2a alone for the retreatment of hepatitis C patients who relapse after a standard course of interferon;Chapman;N.Z. Med. J.,2001

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus Genotype 5 Variability in Treatment-Naïve Patients in South Africa;Intervirology;2023

2. Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy;Microorganisms;2022-08-12

3. Hepatitis C virus treatment failure: Clinical utility for testing resistance-associated substitutions;World Journal of Hepatology;2021-09-27

4. Diversity of the hepatitis C virus NS5B gene during HIV co-infection;PLOS ONE;2020-08-04

5. IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling;Cytokine;2019-12